National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

2011/11/19 by Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach +13 · 2,957 citations
Medicine · Neuroscience · Psychology · #Alzheimer's disease #Alzheimer's disease research and treatments #Association (psychology) #Degenerative disease #Dementia and Cognitive Impairment Research #Disease #Gerontology #Medicine #Neurological Disorders and Treatments #Neuropathology #Neuroscience #Pathology #Psychology

paper · open access · doi:10.1007/s00401-011-0910-3

published in Acta Neuropathologica 123(1), 1-11 (Springer Science+Business Media)

openalex publication_date 2011/11/19 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Citations

• Neuropathological stageing of Alzheimer-related changes

Cited by

• Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
• Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
• Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database
• A guide for blood–brain barrier models
• Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
• Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
• Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease
• Ambient Air Pollution and the Severity of Alzheimer Disease Neuropathology
• Molecular pathology of neurodegenerative diseases: principles and practice
• Semi-Automated Digital Image Analysis of Pick’s Disease and TDP-43 Proteinopathy
• Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals
• Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
• Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
• Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging
• Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
• The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
• Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations
• Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
• Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes
• Integrated multimodal cell atlas of Alzheimer’s disease
• The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center
• Lewy body co‐pathology in Alzheimer's disease and primary age‐related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns
• X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
• Structural Similarity Networks Reveal Brain Vulnerability in Dementia
• Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
• Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
• Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies
• Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease
• Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
• Multiple Neuropathologies Underly Hippocampal Subfield Atrophy in a Case With a Slowly Progressive Amnestic Syndrome: Challenging the Notion of Pure LATE‐NC
• White-matter commissures: a clinically focused anatomical review
• Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
• Multiple system aging‐related tau astrogliopathy with complex proteinopathy in an oligosymptomatic octogenarian
• Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
• Amygdala-predominant Lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer’s disease neuropathological change
• β-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity
• Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease
• Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias
• Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease
• Automatic classification of AD pathology in FTD phenotypes using natural speech
• Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
• Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
• Molecular glue degraders enhance CAPRIN1-dependent lysosomal degradation of APP in Alzheimer’s disease
• Morphological and Hyperphosphorylation Transitions of Nanoscale Tau Aggregates in Alzheimer's Disease
• Distinct neuroinflammatory profiles in progressive supranuclear palsy associated with HLA haplotypes
• Expression pattern of perilipins in human brain during aging and in Alzheimer's disease
• Ageing-related tau astrogliopathy in a population-based study of the oldest old (Vantaa 85+)
• Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's disease
• Air pollution and Alzheimer disease phenotype deplete esterified proresolving lipid mediator reserves in the brain
• When Alzheimer's isLATE: Why Does it Matter?
• Label-free Aβ plaque detection in Alzheimer's disease brain tissue using infrared microscopy and neural networks
• ADNP-15: An Open-Source Histopathological Dataset for Neuritic Plaque Segmentation in Human Brain Whole Slide Images with Frequency Domain Image Enhancement for Stain Normalization
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
• Medial temporal atrophy predicts the limbic comorbidities in lewy body disease
• Multimodal deep learning for Alzheimer’s disease dementia assessment
• Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease
• Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study
• The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy
• The spectrum of disease in chronic traumatic encephalopathy
• The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy
• Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players
• Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions
• Diagnosis and management of dementia with Lewy bodies
• Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. [europepmc]
• Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. [europepmc]
• Neuropathologic substrates of Parkinson disease dementia. [europepmc]
• Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. [europepmc]
• Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. [europepmc]
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. [europepmc]
• Primary age-related tauopathy (PART): a common pathology associated with human aging. [europepmc]
• Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. [europepmc]
• The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. [europepmc]
• Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. [europepmc]
• Alzheimer's disease: experimental models and reality. [europepmc]
• Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football. [europepmc]
• Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. [europepmc]
• NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. [europepmc]
• Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. [europepmc]
• Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. [europepmc]
• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. [europepmc]
• The neuropathological diagnosis of Alzheimer's disease. [europepmc]
• Molecular characterization of selectively vulnerable neurons in Alzheimer's disease. [europepmc]
• New insights into atypical Alzheimer's disease in the era of biomarkers. [europepmc]
• Alzheimer disease. [europepmc]
• Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. [europepmc]
• Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. [europepmc]
• Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. [europepmc]
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. [europepmc]